Estimation of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease

被引:36
|
作者
Spithoven, Edwin M. [1 ]
van Gastel, Maatje D. A. [1 ]
Messchendorp, A. Lianne [1 ]
Casteleijn, Niek F. [1 ]
Drenth, Joost P. H. [2 ]
Gaillard, Carlo A. [1 ]
de Fijter, Johan W. [3 ]
Meijer, Esther [1 ]
Peters, Dorien J. M. [4 ]
Kappert, Peter [5 ]
Renken, Remco J. [6 ]
Visser, Folkert W. [1 ]
Wetzels, Jack F. M. [7 ]
Zietse, Robert [8 ]
Gansevoort, Ron T. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[3] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands
[4] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands
[8] Erasmus MC, Dept Nephrol, Rotterdam, Netherlands
关键词
Autosomal dominant polycystic kidney disease (ADPKD); total kidney volume (TKV); magnetic resonance imaging (MRI); estimation methods; ellipsoid; PANK; validation; ADPKD; PROGRESSION; TOLVAPTAN; TRIALS; DESIGN;
D O I
10.1053/j.ajkd.2015.06.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In autosomal dominant polycystic kidney disease (ADPKD), obtaining measured total kidney volume (mTKV) by magnetic resonance (MR) imaging and manual tracing is time consuming. Two alternative MR imaging methods have recently been proposed to estimate TKV (eTKV(ellipsoid) and eTKV(PANK)), which require less time. Study Design: Cross-sectional and longitudinal diagnostic test study. Setting & Participants: Patients with ADPKD with a wide range of kidney function and an approved T2-weighted MR image obtained at the University Medical Centers of Groningen, Leiden, Nijmegen, and Rotterdam, the Netherlands, in 2007 to 2014. Test set for assessing reproducibility, n = 10; cohort for cross-sectional analyses, n = 220; and cohort for longitudinal analyses, n = 48. Index Tests: Average times for eTKV(ellipsoid) and eTKV(PANK) were 5 and 15 minutes, respectively. Bias is defined as (mTKV - eTKV)/mTKV x 100%; precision, as one standard deviation of bias. Reference Tests: mTKV using manual tracing to calculate the area within kidney boundaries times slice thickness. Average time for mTKV was 55 minutes. Results: In the test set, intra- and intercoefficients of variation for mTKV, eTKV(ellipsoid), and eTKV(PANK) were 1.8% and 2.3%, 3.9% and 6.3%, and 3.0% and 3.4%, respectively. In cross-sectional analysis, baseline mTKV, eTKV(ellipsoid), and eTKV(PANK) were 1.96 (IQR, 1.28-2.82), 1.93 (IQR, 1.25-2.82), and 1.81 (IQR, 1.17-2.62) L, respectively. In cross-sectional analysis, bias was 0.02% +/- 3.2%, 1.4% +/- 9.2%, and 4.6% +/- 7.6% for repeat mTKV, eTKV(ellipsoid), and eTKV(PANK), respectively. In longitudinal analysis, no significant differences were observed between percentage change in mTKV (16.7% +/- 17.1%) and percentage change in eTKV(ellipsoid) (19.3% 6 16.1%) and eTKV(PANK) (17.8% +/- 16.1%) over 3 years. Limitations: Results for follow-up data should be interpreted with caution because of the limited number of patients. Conclusions: Both methods for eTKV perform relatively well compared to mTKV and can detect change in TKV over time. Because eTKV(ellipsoid) requires less time than eTKV(PANK), we suggest that this method may be preferable in clinical care. (C) 2015 by the National Kidney Foundation, Inc.
引用
收藏
页码:792 / 801
页数:10
相关论文
共 50 条
  • [21] Drug repurposing in autosomal dominant polycystic kidney disease
    Zhou, Julie Xia
    Torres, Vicente E.
    KIDNEY INTERNATIONAL, 2023, 103 (05) : 859 - 871
  • [22] Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease
    Horie, Shigeo
    Muto, Satoru
    Kawano, Haruna
    Okada, Tadashi
    Shibasaki, Yoshiyuki
    Nakajima, Koji
    Ibuki, Tatsuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (05) : 467 - 478
  • [23] Magnetic resonance imaging is effective for evaluating the therapeutic effect of tolvaptan on total kidney volume in patients with autosomal dominant polycystic kidney disease
    Hirashio S.
    Doi S.
    Masaki T.
    Renal Replacement Therapy, 4 (1)
  • [24] Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
    Serra, Andreas L.
    Poster, Diane
    Kistler, Andreas D.
    Krauer, Fabienne
    Raina, Shagun
    Young, James
    Rentsch, Katharina M.
    Spanaus, Katharina S.
    Senn, Oliver
    Kristanto, Paulus
    Scheffel, Hans
    Weishaupt, Dominik
    Wuethrich, Rudolf P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) : 820 - 829
  • [25] MRI in autosomal dominant polycystic kidney disease
    Zhang, Weiguo
    Blumenfeld, Jon D.
    Prince, Martin R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 50 (01) : 41 - 51
  • [26] Pregnancy in Autosomal Dominant Polycystic Kidney Disease
    Al Sayyab, Mina
    Chapman, Arlene
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (05): : 454 - 460
  • [27] CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose
    Bevilacqua, Micheli U.
    Hague, Cameron J.
    Romann, Alexandra
    Sheitt, Hana
    Vasilescu, Dragos M.
    Yi, Tae Won
    Levin, Adeera
    RADIOLOGY, 2019, 291 (03) : 660 - 667
  • [28] Kidney Volume Changes in Patients With Autosomal Dominant Polycystic Kidney Disease After Renal Transplantation
    Yamamoto, Takayuki
    Watarai, Yoshihiko
    Kobayashi, Takaaki
    Matsuda, Yoshiko
    Tsujita, Makoto
    Hiramitsu, Takahisa
    Nanmoku, Koji
    Goto, Norihiko
    Katayama, Akio
    Tominaga, Yoshihiro
    Uchida, Kazuharu
    TRANSPLANTATION, 2012, 93 (08) : 794 - 798
  • [29] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396
  • [30] Autosomal dominant polycystic kidney disease
    Chow, Chern Li
    Ong, Albert C. M.
    CLINICAL MEDICINE, 2009, 9 (03) : 278 - 283